Evidence map›Paper›PMID 42079622›Full record

ReviewFrontiers in immunology2026

Dissecting NMOSD pathogenesis through animal models: a mechanism-oriented systems perspective.

Siqi Qiu, Yingyu Zhang, Xiaoshuang Wang, Di Wang, Xuege Zang, Qiurong Yang, Yaxin Qv, Shuai Wang, Xuemei Han

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Siqi Qiu *Department of Neurology, China-Japan Union Hospital of Jilin University, Changchun, China.
Yingyu Zhang *Department of Neurology, China-Japan Union Hospital of Jilin University, Changchun, China.
Xiaoshuang WangDepartment of Neurology, China-Japan Union Hospital of Jilin University, Changchun, China.
Di WangDepartment of Neurology, China-Japan Union Hospital of Jilin University, Changchun, China.
Xuege ZangDepartment of Neurology, China-Japan Union Hospital of Jilin University, Changchun, China.
Qiurong YangDepartment of Neurology, China-Japan Union Hospital of Jilin University, Changchun, China.
Yaxin QvDepartment of Neurology, China-Japan Union Hospital of Jilin University, Changchun, China.
Shuai WangDepartment of Neurology, China-Japan Union Hospital of Jilin University, Changchun, China.
Xuemei HanDepartment of Neurology, China-Japan Union Hospital of Jilin University, Changchun, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuromyelitis optica spectrum disorder (NMOSD) constitutes a demyelinating condition of the central nervous system driven by autoimmune inflammation. A hallmark of its pathogenesis is the antibody-mediated injury of astrocytes, primarily targeting the water channel aquaporin-4 (AQP4). Animal models are indispensable for dissecting disease mechanisms and accelerating the development of new therapies. However, creating models that closely mirror NMOSD remains difficult, in part because immune tolerance limits the induction of the autoreactive responses central to the disease. This review follows NMOSD over time and surveys experimental systems across four interconnected mechanistic themes: breakdown of immune tolerance, T-B cell collaboration, antibody-mediated effector injury, and the formation of pro-inflammatory tissue milieus that sustain pathology. For each theme, we outline the rationale for model design, evaluate how well key pathological features are produced, and discuss the limitations that shape interpretation. Rather than offering a single continuous reconstruction of human NMOSD, these platforms capture complementary and only partially overlapping aspects of pathogenesis. Taken together, they provide a mechanism-oriented framework for understanding how upstream immune dysregulation, humoral immunity, and tissue-level permissive factors shape disease expression. At the same time, they also highlight the distance between experimental systems and the heterogeneous, dynamic course seen in patients. We further discuss how findings from animal studies are informing therapeutic target discovery and outline priorities for the development of next-generation models with greater translational relevance.

Indexed as

Disease Models, AnimalNeuromyelitis OpticaAnimalsAquaporin 4AstrocytesB-LymphocytesHumansImmune ToleranceAquaporin 4animal modelsaquaporin-4neuromyelitis optica spectrum disorderspathogenesistranslational medicine

Identifiers

PMID42079622
PMCPMC13132812

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.